Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
71.50
+1.20 (1.71%)
Apr 2, 2025, 1:30 PM CST
TPEX:4747 Revenue
In the year 2024, Johnson Chemical Pharmaceutical Works had annual revenue of 611.42M TWD with 0.78% growth. Johnson Chemical Pharmaceutical Works had revenue of 147.82M in the quarter ending December 31, 2024, a decrease of -4.47%.
Revenue
611.42M
Revenue Growth
+0.78%
P/S Ratio
5.26
Revenue / Employee
3.60M
Employees
167
Market Cap
3.21B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 611.42M | 4.70M | 0.78% |
Dec 31, 2023 | 606.71M | 112.04M | 22.65% |
Dec 31, 2022 | 494.67M | 83.18M | 20.21% |
Dec 31, 2021 | 411.49M | -12.52M | -2.95% |
Dec 31, 2020 | 424.02M | -1.32M | -0.31% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Oneness Biotech | 117.93M |
Lumosa Therapeutics | 39.15M |
Pegavision | 6.82B |
Center Laboratories | 1.62B |